Tudor Investment Corp’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.9K Buy
115,237
+65,237
+130% +$103K ﹤0.01% 3495
2025
Q4
$155K Sell
50,000
-103
-0.2% -$294 ﹤0.01% 3341
2025
Q3
$132K Buy
50,103
+3,639
+8% +$8.02K ﹤0.01% 3245
2025
Q2
$57.2K Hold
46,464
﹤0.01% 3163
2025
Q1
$51.1K Hold
46,464
﹤0.01% 2956
2024
Q4
$42K Hold
46,464
﹤0.01% 2934
2024
Q3
$45.8K Hold
46,464
﹤0.01% 2619
2024
Q2
$41.9K Hold
46,464
﹤0.01% 2235
2024
Q1
$54.8K Hold
46,464
﹤0.01% 2111
2023
Q4
$42.4K Hold
46,464
﹤0.01% 2272
2023
Q3
$38.7K Hold
46,464
﹤0.01% 2190
2023
Q2
$55.8K Hold
46,464
﹤0.01% 2321
2023
Q1
$59K Buy
+46,464
New +$88.9K ﹤0.01% 2279
2022
Q4
Sell
-46,867
Closed -$561K 2561
2022
Q3
$561K Buy
+46,867
New +$582K 0.01% 1314
2021
Q2
Sell
-36,064
Closed -$334K 1713
2021
Q1
$334K Buy
36,064
+20,893
+138% +$211K 0.01% 1272
2020
Q4
$147K Buy
15,171
+2,125
+16% +$20.9K ﹤0.01% 1256
2020
Q3
$162K Buy
+13,046
New +$173K 0.01% 1151

Other funds holding GOSS

Tudor Investment Corp's GOSS Position: Q1 2026 in Review

Tudor Investment Corp increased its Gossamer Bio (GOSS) stake by 130% in Q1 2026, buying an estimated $103K and bringing the position to 115,237 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

Tudor Investment Corp first reported a position in GOSS in Q3 2020 and has held it in 17 quarters since. The position peaked at $561K in Q3 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Tudor Investment Corp held 115,237 shares of Gossamer Bio worth $37.9K as of Q1 2026.
  • Tudor Investment Corp bought 65,237 Gossamer Bio shares in Q1 2026, an estimated $103K.
  • Gossamer Bio made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #3495 holding.
  • Tudor Investment Corp first reported a position in Gossamer Bio in Q3 2020 and has held it in 17 quarters since.
  • Tudor Investment Corp's Gossamer Bio position peaked at $561K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.